Why Patients Travel Abroad for IVF

Legal limits, waiting, cost and donor frameworks: what the evidence says about each driver, and what travel can't change.

Bottom line up front: Research on cross-border fertility care points to four main reasons people travel: legal restrictions at home, long waits, lower cost, and a legal framework that suits them better, such as particular donor rules. Each reason calls for a different first check. Travel can change access, timing and price. It can't change the biology of age, or remove the risks of treatment.

People don't travel for IVF for one reason. For some, the treatment they need isn't available to them at home. Others face a long wait, a price they can't manage, or rules that don't fit their family. Knowing which reason applies to you matters because it decides what you should compare first. This article sets out what the evidence says about each driver, with the cautions regulators attach.

How common is cross-border IVF?

ESHRE, the European Society of Human Reproduction and Embryology, estimated from a decade of surveys that around 5% of fertility care in Europe involves patients crossing borders. Spain and Belgium were the most visited countries within Europe, and the United States was a major destination worldwide. ESHRE's fact sheet also reports a CDC analysis of 2013 US cycles in which almost 3% were for non-US residents (ESHRE fact sheet on cross-border reproductive care, 2017). These figures are several years old, but they show that IVF travel is an established pattern rather than a fringe one.

Driver 1: Legal restrictions at home

ESHRE's fact sheet describes patients travelling to avoid legal restrictions at home. At the time it was written, its examples were single and lesbian women in France and preimplantation genetic diagnosis in Germany. Laws change, so treat these as examples of the pattern rather than a description of current rules in those countries. The CDC's guidance on medical tourism also lists restrictive policies among the barriers that lead people to seek fertility care abroad (CDC Yellow Book, 2026).

A destination's own law is what makes it an option. Spain's assisted reproduction law, for example, allows women over 18 to be treated regardless of marital status or sexual orientation (Ley 14/2006, BOE). On the other hand, the HFEA notes that only a limited number of countries treat single women or same-sex couples, and that some allow donor sperm but not donor eggs or embryos (HFEA, 2016).

Check first if this is your driver: confirm that the specific treatment is legal for someone in your situation at the destination, and that any results, such as embryos or legal parenthood, will be recognised where you live. Our global access map is a starting point.

Driver 2: Waiting lists

ESHRE gives waiting lists for egg donation in the UK as an example of what drives travel, and describes Spain as known for short waits and plentiful donor gametes. The CDC also names long waiting lists as a reason people go abroad.

The UK regulator adds an important counterpoint. The HFEA notes that some people go abroad to avoid a donor waiting list, but that many UK clinics have no list or only a short one, especially for IVF with donor eggs. It publishes clinic waiting times so patients can check. The lesson applies anywhere: before travelling to beat a wait, check how long the wait actually is at several clinics at home.

Check first if this is your driver: get current wait times in writing from home clinics, then compare them with the full timeline abroad, including testing, matching and travel planning, not just the first available date.

Driver 3: Cost

Lower cost is one of the reasons ESHRE lists, and the CDC names high costs at home as a barrier. Cost is also where comparisons most often go wrong. The HFEA warns that low IVF prices abroad may exclude drugs, blood tests or the first consultation, and tells patients to budget for accommodation, flights, specialist medical insurance and unpaid leave, with a contingency fund for when things go wrong.

Cost differences are real, but what matters is the full figure for your realistic number of cycles, including the possibility of a second trip.

Check first if this is your driver: get itemised written quotes, add travel and time-off costs, and compare against the full price at home. Our IVF abroad vs at home guide shows how to set that comparison up.

Driver 4: A framework that fits you better

ESHRE also describes patients seeking a "more personally suitable" framework, with donor anonymity as its example. Some patients prefer anonymous donation, while others specifically want a donor their child can identify later. The rules differ sharply between countries. The HFEA explains that UK donor-conceived people can request identifying information at 18, while some countries allow fully anonymous donation, so a child may never be able to trace the donor.

Framework fit also covers family limits per donor, embryo storage rules and transfer policies. These are often the reason a patient chooses one country over another that's equally accessible and similarly priced.

Check first if this is your driver: read the destination's donor and storage rules in an official source, and think about what your future child may want to know.

A fifth reason to treat with caution: success-rate claims

The CDC notes that some people believe care abroad is higher quality. The HFEA observes that some clinics abroad advertise very high success rates, and warns that clinics may present selective figures, such as results only for women under 35, or pregnancy rates rather than live births. Clinics that treat younger patients with milder problems will naturally show higher rates.

Encouragingly, ESHRE's fact sheet reports that the CDC analysis found comparable embryo transfer and live birth rates for US and non-US residents treated in the US. Travelling doesn't in itself make outcomes worse. But a headline success rate is a poor reason on its own to choose a destination. See what IVF success rates abroad actually mean.

What travel doesn't change

When staying home may be the better answer

Looking at the reasons for travel honestly also shows when it may not be worth it:

None of these rules out treatment abroad, but each is a reason to pause and recheck the numbers.

Find your main driver

If your main reason is…Your first question is…Then weigh…
Legal accessIs this treatment legal for me there, and will the outcome be recognised at home?Clinic quality and follow-up
Waiting timeHow long is the wait at home, really, and what's the full timeline abroad?Cost and travel burden
CostWhat's the full price for my likely number of cycles in each place?Quality signals and logistics
Framework fitDo the donor, storage and transfer rules match my values?Access and cost

Most patients have a main driver and one or two secondary ones. Naming them before you look at clinics keeps the comparison honest.

The Takeaway

Legal limits, waiting, cost and framework fit are all valid reasons to look abroad, and each needs its own first check. Be most sceptical of headline success rates, and remember that travel changes where you're treated, not your own biology or the need for follow-up care at home.

Frequently asked questions

What is cross-border reproductive care?

It's the term ESHRE uses for fertility treatment that patients travel outside their home country to receive. You'll also see it called "reproductive tourism".

Is IVF abroad less safe than IVF at home?

Not inherently, but standards, regulation and oversight vary between countries and clinics. The HFEA notes that not every country regulates fertility treatment, so check which regulator and rules apply to any clinic you're considering.

Is travelling to avoid a waiting list always faster?

Not always. The HFEA points out that many UK clinics have short or no donor waiting lists. Compare real wait times at home with the full timeline abroad, including tests and matching.

Are clinics abroad allowed to treat single women?

It depends on the country. Spain's law permits treatment of women over 18 regardless of marital status, but the HFEA notes that only a limited number of countries treat single women or same-sex couples.

Should I choose a destination based on its success rates?

Not on headline rates alone. Ask how figures are calculated, which patients they include, and whether they report live births. Then weigh them alongside access, cost and follow-up.